Research Calls I
-
Upgrades
- Consolidated Edison (ED) upgraded to Outperform from Neutral at Mizuho, tgt $107
- Disney (DIS) upgraded to Buy from Hold at Jefferies, tgt $144
- Kratos Defense (KTOS) upgraded to Buy from Neutral at Goldman, tgt $52
- Linde (LIN) upgraded to Buy from Neutral at Citigroup, tgt $535
- Medtronic (MDT) upgraded to Peer Perform from Underperform at Wolfe Research
- Oracle (ORCL) upgraded to Buy from Hold at Stifel, tgt $250
- Vor Bio (VOR) upgraded to Buy from Neutral at H.C. Wainwright, tgt $3
- Consolidated Edison (ED) upgraded to Outperform from Neutral at Mizuho, tgt $107
-
Downgrades
- ProKidney (PROK) downgraded to Underperform from Neutral at BofA Securities, tgt $1
- Tronox (TROX) downgraded to Underperform from Market Perform at BMO Capital, tgt $3
- ProKidney (PROK) downgraded to Underperform from Neutral at BofA Securities, tgt $1
-
Others
- Aardvark Therapeutics (AARD) initiated with a Buy at H.C. Wainwright, tgt $40
- AeroVironment (AVAV) initiated with a Buy at Goldman, tgt $301
- American Healthcare REIT (AHR) initiated with an Outperform at Scotiabank, tgt $42
- Amplify Energy (AMPY) resumed with a Buy at Alliance Global Partners, tgt $6
- Amrize (AMRZ) initiated with a Buy at Berenberg, tgt $64
- Amrize (AMRZ) initiated with a Hold at Jefferies, tgt $52.50
- Aytu BioPharma (AYTU) initiated with a Buy at Ascendiant, tgt $12
- Brookfield Asset Management (BAM) initiated with a Neutral at Piper Sandler, tgt $60
- Capricor Therapeutics (CAPR) initiated with a Buy at Alliance Global Partners, tgt $20
- Candel Therapeutics (CADL) assumed with a Buy at H.C. Wainwright, tgt $23
- CAE (CAE) assumed with a Buy at Goldman, tgt $33
- Circle (CRCL) initiated with an Underperform at Autonomous, tgt $147
- Circle (CRCL) initiated with a Buy at Needham, tgt $250
- Circle (CRCL) initiated with an Underweight at JPMorgan, tgt $80
- Circle (CRCL) initiated with a Perform at Oppenheimer
- Circle (CRCL) initiated with an Outperform at Bernstein, tgt $230
- Circle (CRCL) initiated with an Overweight at Barclays, tgt $215
- Circle (CRCL) initiated with a Neutral at Goldman, tgt $83
- Compass (COMP) assumed with a Buy at BTIG Research, tgt $9
- Dutch Bros (BROS) initiated with an Outperform at CICC, tgt $80
- Driven Brands (DRVN) initiated with a Buy at BTIG Research, tgt $22
- Edgewise Therapeutics (EWTX) initiated with a Buy at H.C. Wainwright, tgt $42
- First Busey (BUSE) initiated with a Market Perform at Hovde Group
- KKR (KKR) initiated with an Overweight at Piper Sandler, tgt $150
- Leonardo DRS (DRS) initiated with a Buy at Goldman, tgt $49
- Mister Car Wash (MCW) initiated with a Neutral at BTIG Research
- Planet Labs (PL) assumed with a Neutral at Goldman, tgt $4.60
- Rocket Lab (RKLB) assumed with a Neutral at Goldman, tgt $27
- SailPoint (SAIL) initiated with an Overweight at Cantor Fitzgerald, tgt $29
- Starbucks (SBUX) initiated with an Outperform at CICC, tgt $100
- Virgin Galactic (SPCE) assumed with a Neutral at Goldman, tgt $3
- Waystar (WAY) initiated with an Outperform at Mizuho, tgt $48
- Wells Fargo (WFC) initiated with an Outperform at KGI Securities, tgt $93
- Aardvark Therapeutics (AARD) initiated with a Buy at H.C. Wainwright, tgt $40